Evernest Financial Advisors LLC Has $863,000 Stock Holdings in Abacus Life, Inc. (NASDAQ:ABL)

Evernest Financial Advisors LLC increased its stake in Abacus Life, Inc. (NASDAQ:ABL - Free Report) by 63.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 110,250 shares of the company's stock after purchasing an additional 42,950 shares during the quarter. Evernest Financial Advisors LLC owned about 0.13% of Abacus Life worth $863,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. Richard W. Paul & Associates LLC grew its position in Abacus Life by 27.8% in the third quarter. Richard W. Paul & Associates LLC now owns 38,902 shares of the company's stock worth $394,000 after buying an additional 8,454 shares during the last quarter. Renaissance Technologies LLC acquired a new position in shares of Abacus Life in the second quarter worth about $106,000. Curi RMB Capital LLC increased its position in shares of Abacus Life by 2.4% in the third quarter. Curi RMB Capital LLC now owns 550,000 shares of the company's stock worth $5,566,000 after acquiring an additional 12,765 shares in the last quarter. Geneos Wealth Management Inc. acquired a new stake in shares of Abacus Life during the fourth quarter valued at approximately $110,000. Finally, Franklin Resources Inc. lifted its position in shares of Abacus Life by 3.6% in the 3rd quarter. Franklin Resources Inc. now owns 437,733 shares of the company's stock valued at $4,382,000 after acquiring an additional 15,308 shares in the last quarter.

Abacus Life Stock Performance

Abacus Life stock traded up $0.09 on Tuesday, reaching $7.76. 279,424 shares of the stock were exchanged, compared to its average volume of 210,744. The stock has a market cap of $750.12 million, a PE ratio of -43.12 and a beta of 0.14. The firm has a fifty day moving average price of $7.73 and a two-hundred day moving average price of $8.97. Abacus Life, Inc. has a twelve month low of $6.75 and a twelve month high of $13.25. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.65.

Abacus Life (NASDAQ:ABL - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.14 by $0.06. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The company had revenue of $28.15 million during the quarter, compared to analyst estimates of $26.08 million. During the same period in the previous year, the company earned $0.01 earnings per share. Sell-side analysts anticipate that Abacus Life, Inc. will post 0.62 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. B. Riley decreased their target price on Abacus Life from $17.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Northland Securities assumed coverage on Abacus Life in a research note on Thursday, October 24th. They set an "outperform" rating and a $13.50 target price on the stock. Piper Sandler reissued an "overweight" rating and set a $13.00 target price (up previously from $12.00) on shares of Abacus Life in a research note on Friday, November 8th. Finally, Northland Capmk raised Abacus Life to a "strong-buy" rating in a research report on Thursday, October 24th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $14.30.

Insider Activity at Abacus Life

In other Abacus Life news, CEO Jay J. Jackson sold 2,031,250 shares of the firm's stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $8.00, for a total value of $16,250,000.00. Following the completion of the sale, the chief executive officer now owns 10,562,000 shares in the company, valued at approximately $84,496,000. This trade represents a 16.13 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Adam Samuel Gusky purchased 18,241 shares of the stock in a transaction on Friday, November 22nd. The stock was acquired at an average cost of $7.54 per share, for a total transaction of $137,537.14. Following the acquisition, the director now directly owns 40,959 shares in the company, valued at approximately $308,830.86. This trade represents a 80.29 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 36,367 shares of company stock worth $279,626 and sold 2,263,300 shares worth $18,106,400. Corporate insiders own 79.20% of the company's stock.

Abacus Life Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.